document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center license agreement style margin margin bottom font size font family time roman align center between style margin margin bottom font size font family time roman align center takeda pharmaceutical company limited style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center tobira therapeutic style margin margin bottom font size font family time roman align center dated august nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style page break before always size style color width align center style margin margin bottom font size font family time roman align center table content style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign style margin left text indent font size font family time roman definition valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman grant license valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman patent assignment valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman consideration valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman disclosure information technology transfer valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman development work valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman regulatory matter valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman manufacturing valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman sale product report valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman representation warranty valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman indemnification valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman secrecy valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman patent valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman invention improvement valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman force majeure valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman term agreement termination valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman effect breach termination valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman limitation liability valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman assignment valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman severability valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman entire agreement modification valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman official text governing valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman notice valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman arbitration valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman construction valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman counterpart valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman article nbsp valign bottom valign bottom style margin left text indent font size font family time roman waiver valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size font family time roman list schedule style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width style font family time roman font size valign bottom style margin left text indent font size font family time roman schedule style font family time roman font size valign bottom style margin left text indent font size font family time roman schedule style font family time roman font size valign bottom style margin left text indent font size font family time roman schedule style font family time roman font size valign bottom style margin left text indent font size font family time roman schedule style font family time roman font size valign bottom style margin left text indent font size font family time roman schedule style font family time roman font size valign bottom style margin left text indent font size font family time roman schedule style font family time roman font size valign bottom style margin left text indent font size font family time roman schedule table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center license agreement style margin margin bottom font size font family time roman this agreement made august between takeda pharmaceutical company limited with head office doshomachi chome chuo osaka japan hereinafter called takeda tobira therapeutic with principal office high bluff drive suite diego hereinafter called tobira style margin margin bottom font size font family time roman align center witnesseth that style margin margin bottom font size font family time roman whereas takeda owner compound hereinafter defined being chemokine motif receptor antagonist certain information hereinafter defined assigned patent hereinafter defined ancillary patent hereinafter defined which cover cover compound product hereinafter defined style margin margin bottom font size font family time roman whereas tobira company which posse intends posse expertise resource relating development manufacture marketing sale chemical entity pharmaceutical product including those treatment human immunodeficiency virus other disorder human body style margin margin bottom font size font family time roman whereas tobira wish obtain exclusive license from takeda development manufacture commercialization compound product style margin margin bottom font size font family time roman whereas takeda willing grant such exclusive licence tobira under term condition hereinafter forth style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman therefore party hereto agree follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small efinitions small table style margin margin bottom font size font family time roman following term whenever used this agreement shall have following meaning style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign access programme shall mean with respect product primary indication hereinafter defined nbsp donation product free charge nbsp transfer product published price agreed with unaids world bank each case governmental organisation other public health body charity administration individual country designated world bank belonging poorest current list which country hereby attached hereto schedule table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign affiliate shall mean with respect party corporation entity person that directly indirectly control controlled under common control with such party only long such control exists purpose this definition control mean nbsp case corporate entity direct indirect ownership fifty percent nbsp more stock share entitled vote election director nbsp case corporate entity direct indirect ownership fifty percent nbsp more equity interest with power direct management policy such corporate entity table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign ancillary patent shall mean patent patent application defined article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign approval shall mean permission approval governmental health authority country jurisdiction territory required commercialisation product such country jurisdiction including without limitation pricing reimbursement approval applicable table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign assigned patent shall mean patent patent application defined article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign combination product shall have meaning forth article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign commercially reasonable effort shall mean effort resource commonly used similarly situated company research based pharmaceutical industry compound product similar market commercialisation prospect similar stage product life cycle compound product taking into account stage development commercialisation compound product cost effectiveness effort resource while optimising profitability competitiveness alternative compound product which expected marketplace patent other proprietary position compound product commercial potential compound product other reasonable relevant factor including without limitation technical legal scientific medical factor table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign competing product shall have meaning forth article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign compound shall mean principal compound hereinafter defined reserve compound hereinafter defined table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information shall mean data information disclosed party including affiliate sublicensees other party accordance with furtherance this agreement including without limitation information status result development work confidential information includes information about application made approval planned expected launch date product other commercial competitive information product table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign packaged product shall have meaning forth article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign development work shall mean clinical clinical study compilation dossier concerning compound product other work conducted hereunder which necessary obtaining approval table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign effective date shall mean date first mentioned above table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign first commercial sale shall mean first sale consumption product each country territory after approval such country obtained table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign generic entry mean nbsp consecutive calendar quarter period during which more third party have sold number unit generic version product certain country equal greater than total unit sale such product such generic version such country same period taken together aggregate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign generic version mean product that includes active ingredient that identical chemical structure activity active ingredient product that received regulatory approval through abbreviated filing application under section nbsp food drug nbsp cosmetic foreign equivalent foregoing that reference approval product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign mean investigational drug application defined applicable regulation promulgated regulatory authority territory filing which necessary commence conduct clinical testing pharmaceutical product human territory table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnified party shall have meaning forth article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnifying party shall have meaning forth article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign information shall mean clinical clinical data manufacturing know regulatory filing regulatory communication with regulatory authority with regard compound product nbsp which owned available takeda effective date nbsp were used applied takeda development manufacture compound product before effective date nbsp reasonably believed takeda effective date relevant information provided listed information list attached hereto schedule table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign loss shall have meaning forth article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign shall mean marketing authorisation application related product amendment supplement thereto submitted emea with intention gaining approval registration allow marketing sale product european union table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign shall mean drug application related product amendment supplement thereto submitted with intention gaining approval registration allow marketing sale product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign sale shall mean actual gross amount invoiced tobira affiliate sublicensee sale other commercial disposition product third party wholesaler customer amount added pursuant article nbsp following deduction with respect such sale table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign rebate quantity trade cash discount other usual customary discount customer table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign compulsory payment rebate actually paid deducted table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign retroactive price reduction credit allowance actually granted upon rejection return product including recall damaged good table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign deduction actual debt when such debt could collected following issuance tobira affiliate sublicensee invoice despite applying commercially reasonable effort extent relating product should tobira able recover part such debt such amount should added sale without delay table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign freight postage shipping insurance charge actually allowed paid delivery product extent included gross sale price table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sale excise import export duty other governmental charge actually incurred with respect such sale including without limitation value added table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign charge back payment rebate granted managed health care organisation federal state local government their respective agency purchaser reimbursers table style margin margin bottom margin left font size font family time roman incurred tobira affiliate sublicensee ordinary course business type amount consistent with good industry practice determined accordance with gaap consistently applied only extent actually incurred tobira affiliate sublicensee relation corresponding sale product sake style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman clarity avoidance doubt nbsp individual rebate discount other deduction should deducted twice calculation sale nbsp sale product among tobira affiliate sublicensee considered sale third party product used promotional advertising purpose used clinical other research purpose donation shall included sale sale adjusted necessary each financial year accordance with gaap consistently applied style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign party party shall mean either party both party hereto respectively table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign phase trial shall mean clinical trial which initiated after successful conclusion phase process with equivalent process with emea which emea agrees that design trial will adequately meet requirement demonstrate safety efficacy product order achieve approval product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign primary indication shall mean treatment infection table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign principal compound shall mean table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign principal product shall have meaning forth article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign product shall mean pharmaceutical preparation human which contains compound active ingredient whether combination with other active ingredient table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign public health access license shall mean license permission granted whether compulsorily enforced voluntarily third party with respect development manufacture distribution sale product primary indication primary purpose which allow such third party freedom operate under assigned patent developing country other certain defined area table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign reserve compound shall mean table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign reserve product shall have meaning forth article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign royalty period shall have meaning forth article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign secondary indication shall mean treatment prevention diagnosis indication that primary indication table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign specific compound shall mean compound identified schedule attached hereto table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign sublicensee shall mean third party whom tobira granted sublicenses compound product pursuant article except third party whom public health access license been granted table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign territory shall mean country world table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign third party shall mean party other than party this agreement respective affiliate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign trademark shall have meaning forth article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small rant small small small small icense small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size exclusive right subject term condition contained herein subject takeda receipt payment tobira upfront milestone pursuant article takeda shall grant tobira tobira shall accept exclusive license with right license under information solely develop manufacture make have made sell offer sale import export compound product territory primary indication secondary indication table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign under trademark owned selected tobira understood that meaning exclusive foregoing sentence exclusive other than license under otherwise related public health access license granted governmental authority even takeda compliance with requirement governmental authority third party pursuant article grant third party public health access license under information such grant shall affect this agreement shall constitute breach takeda this agreement unless otherwise agreed upon party hereto tobira shall have right information purpose other than those specifically forth first sentence this article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign blocking provision addition subject term condition contained herein subject takeda receipt tobira payment upfront milestone pursuant article takeda shall enforce with respect table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign patent patent application listed schedule attached hereto including patent arising from such application addition division continuation continuation part substitution extension renewal reissue confirmation import thereof therefor including their extension table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign other patent patent application obtained submitted takeda during term this agreement claim example patent application which specific reference either both compound made other than those specified above subsection table style margin margin bottom margin left font size font family time roman hereinafter above nbsp nbsp collectively referred ancillary patent against tobira affiliate sublicensee style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman their permitted successor assigns with regard development manufacture commercialisation compound product territory during term ancillary patent avoidance doubt such enforcement commitment takeda shall apply only with regard development manufacture commercialisation compound product territory takeda shall restricted enforce ancillary patent against tobira affiliate sublicensee their permitted successor assigns with regard other purpose with regard ancillary patent takeda shall under obligation including without limitation obligation prosecute maintain ancillary patent takeda shall entitled dispose abandon modify them sole discretion provided however that takeda nbsp shall grant license affiliate third party under ancillary patent which conflict with covenant granted tobira hereunder nbsp shall transfer ancillary patent affiliate third party without securing covenant granted tobira hereunder there exist other patent patent application which fall under above mentioned definition ancillary patent then such patent patent application shall added treated ancillary patent style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign obligation licensing granting right except otherwise provided article tobira shall impose affiliate sublicensee third party marketing partner obligation imposed hereunder tobira including without limitation those specifically stipulated herein obligation tobira affiliate sublicensee shall responsible takeda performance such obligation only itself also affiliate sublicensee third party marketing partner table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign trademark tobira shall market product throughout territory under trademark trademark selected tobira among from tobira trademark inventory collectively trademark except otherwise expressly provided this agreement tobira shall right title interest such trademark takeda hereby acknowledges tobira exclusive ownership right trademark tobira name logo table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign general access therapy public health ground tobira takeda aware that product could become important milestone fight against takeda also recognizes fact that tobira actively support under ethical aspect effective strategy initiative programme governmental well other governmental private organization particularly developing world fight against consideration thereof nothing this agreement shall restrict tobira circumstance which tobira considers reasonable grant public health access license assigned patent information make product available through access programme provided however that tobira shall notify takeda writing thereof after granting such public health access license commencing such access programme tobira shall obligated impose licensee under public health access license obligation imposed hereunder tobira provided however that tobira grant public health access license tobira make product available through access programme tobira shall always tobira sole cost risk responsibility table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size combination product packaged product tobira shall further have right market distribute sell nbsp combination product formulation product which contains least nbsp other table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign therapeutically active ingredient addition compound combination product nbsp product single packaged product containing product more active ingredient separate component font style white space nowrap packaged font product avoidance doubt foregoing sentence shall mean that takeda hereby grant shall obligated grant tobira license develop commercialize other takeda proprietary compound than compound even such other takeda proprietary compound nbsp used combination with compound nbsp packaged commercialized with product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small atent small small ssignment small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size assigned patent subject term condition contained herein subject takeda receipt tobira payment upfront milestone pursuant article takeda shall assign transfer irrevocably subject takeda right request transfer abandon pursuant article hereof tobira tobira shall accept such assignment transfer take over patent patent application listed patent list attached hereto schedule nbsp accordance with term condition herein provided however takeda before such assignment delete amend disclaim claimed invention other than those compound claimed invention composition matter compound from such patent patent application move such deleted amended disclaimed invention part whole into other patent patent application derived therefrom patent patent application listed patent list attached hereto schedule nbsp after such deletion amendment disclaimer taken shall hereinafter called assigned patent patent patent application thus made moving table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign deleted amended disclaimed invention shall hereinafter called other patent takeda shall take necessary procedure such deletion amendment disclaimer within three nbsp month after receipt tobira payment upfront milestone pursuant article avoidance doubt takeda shall under obligation including without limitation obligation prosecute maintain other patent takeda shall entitled dispose abandon modify such other patent sole discretion provided however such other patent fall under definition ancillary patent forth article then such other patent shall added treated ancillary patent table style margin margin bottom margin left font size font family time roman takeda desire dispose abandon part scope other patent which part scope cover invention specific compound composition matter specific compound hereinafter called specific compound scope takeda shall provide tobira with thirty nbsp prior written notice such desire tobira request within such thirty nbsp shall provide tobira with opportunity prosecute maintain such specific compound scope tobira expense such case style margin margin bottom margin left font size font family time roman nbsp takeda shall assign such specific compound scope tobira tobira shall take necessary procedure ownership change tobira cost responsibility within nbsp year after above takeda notice style margin margin bottom margin left font size font family time roman nbsp thereafter specific compound shall treated included definition principal compound style margin margin bottom margin left font size font family time roman nbsp specific compound scope shall treated included definition assigned patent style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size ownership change within nbsp year after execution this agreement after takeda taken necessary action delete table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign amend disclaim claimed invention other than those compound move such deleted amended disclaimed invention into other patent forth article tobira shall responsibility expense take necessary procedure assignment change name patent application owner from takeda tobira takeda shall cooperate with tobira such procedure including without limitation signing submitting tobira document prepared tobira such patent application owner name change tobira cost avoidance doubt tobira shall take procedure assignment assigned patent until unless takeda deleted amended disclaimed claimed invention other than those compound taken necessary action move such deleted amended disclaimed invention into other patent forth article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign maintenance assigned patent after assignment assigned patent such assigned patent including specific compound scope after such specific compound scope assigned tobira pursuant above article shall maintained tobira discretion responsibility expense pursuant article tobira shall without obtaining takeda prior written consent attempt expand scope what claimed assigned patent file divisional continuous patent application continuous part patent application derived from assigned patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small onsideration small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size front milestone payment part consideration patent assignment license grant takeda hereunder tobira shall make following milestone payment takeda each which shall table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign once only upon occurrence following respective trigger event payable dollar pursuant following instalment within nbsp thirty nbsp after respective trigger event with regard instalment below nbsp only with regard instalment under following within sixty nbsp after first calendar year which table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign bottom nbsp valign bottom nbsp nbsp valign bottom align center style border bottom solid trigger nbsp event valign bottom nbsp nbsp valign bottom align center style border bottom solid milestone nbsp payment style font size height height colspan height colspan bgcolor cceeff style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center table style margin margin bottom margin left font size font family time roman avoidance doubt nbsp should become clear that relevant milestone payment corresponding mentioned above case shall time when such fact becomes clear even such fact become clear such payment shall latest together with immediately following milestone payment upon occurrence such immediately following trigger event nbsp each milestone shall payable only once first achievement relevant milestone event tobira shall required make milestone payment product containing reserve compound hereinafter called reserve product same trigger event which tobira already made such milestone payment with regard product containing principal compound hereinafter called principal product vice versa stipulated article style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign royalty calculation payment addition consideration provided article hereof accordance with term this agreement tobira shall takeda tiered royalty dollar based cumulative worldwide annual sale product sold territory tobira affiliate sublicensee each calendar year according sliding scale below each country territory tobira shall takeda royalty period commencing date first commercial sale first product such country ending later following table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign twelfth nbsp anniversary first commercial sale product such country generic entry whichever earlier table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign date expiration last expire assigned patent such country calculated country country basis hereinafter called royalty period royalty shall paid quarterly tobira takeda within sixty nbsp after last each quarter rate royalty annual sale territory during royalty period shall follows table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign portion such sale product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign portion such sale product over table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign portion such sale product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign portion such sale product over table style margin margin bottom margin left font size font family time roman avoidance doubt nbsp principal product reserve product shall hereunder treated independently relation duration royalty period royalty period reserve product shall continue country country basis regardless royalty period principal product until later nbsp twelfth nbsp anniversary first commercial sale reserve product such country generic entry whichever earlier nbsp date expiration last expire assigned patent reserve compound reserve product nbsp calculation annual sale both style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman principal product reserve product shall calculated into example certain year sale principal product which subject royalty payment sale reserve product which subject royalty payment then amount royalty such year pursuant hereto style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign exempt sale transfer notwithstanding provision this article tobira shall obligated royalty transfer compound product within scope access programme even such transfer give rise sale provided however that price compound product thus transferred tobira within scope access programme exceeds then prevailing average selling price compound product transferred third party tobira sublicensee united state then such transfer product shall deemed made under access programme tobira shall obligated royalty takeda such transfer well table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign royalty from public health access license event that tobira earns revenue from public health access license tobira shall obligated royalty such revenue takeda such public health access license granted consideration running royalty rate which more than sale product such third party public health access license granted tobira consideration running royalty rate which more than sale product such third party then portion running royalty exceeding sale product such third party shall added sale table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign third party patent essential desirable tobira exploit license granted takeda under this agreement country that tobira obtains license from more third party under such third party issued patent patent then tobira shall obtain such license risk cost table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign combination product packaged product sale combination product packaged product shall calculated multiplying total sale combination product packaged product fraction where tobira affiliate sublicensee applicable country product containing compound sole therapeutically active ingredient sold separately same formulation dosage having same approved indication weighted gross sale calendar quarter which royalty being calculated hereunder applicable country product containing each other active ingredient their sole therapeutically active ingredient combination product separate component packaged with product sold separately same formulation dosage having same approved indication during applicable calendar quarter determined because value product other product containing other active ingredient than compound sold alone available particular country question then thus available case shall average price weighted gross sale calendar quarter which royalty being calculated hereunder which product other active ingredient sold alone dosage included combination product packaged product event that product other active ingredient sold alone country territory party shall negotiate good faith allocation fair market value product combination product packaged product table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign sale royalty reporting from date first commercial sale until expiry royalty period within sixty nbsp each calendar quarter tobira shall send takeda report product product basis stating nbsp gross sale sale product sold tobira affiliate sublicensee country country basis local currency with respect such calendar quarter nbsp currency exchange rate used determine royalty payable nbsp calculation amount payable takeda pursuant this article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign withholding income payment made takeda under this agreement shall borne takeda tobira shall deduct withholding other statutory duty levied payment tobira takeda pursuant this agreement shall such withholding other statutory duty proper authority required applicable date payment tobira shall maintain official receipt payment withholding forward these receipt takeda without undue delay party shall exercise reasonable effort ensure that withholding other statutory duty imposed reduced possible under provision current future double taxation agreement between japan table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign conversion rate conversion from other currency into dollar shall made using daily rate exchange published wall street journal eastern edition last working calendar quarter which payment relates table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size audit right tobira sublicensee shall keep accurate record sufficient detail concerning sale product takeda table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign have audited tobira affiliate sublicensee independent public accountant reasonably acceptable tobira relevant account book their relating record document possessed tobira concerning sale product such examination shall conducted nbsp upon least thirty nbsp prior written notice tobira during normal business hour however more than once calendar year nbsp facility where such record kept nbsp without unreasonable disruption operation tobira nbsp sole purpose verifying correctness payment made takeda hereunder such independent public accountant required enter into separate reasonable confidentiality agreement with tobira shall under circumstance entitled report takeda detail review except confirming level royalty payment achievement trigger event milestone payment case such accountant find underpayment more than tobira shall bear cost expense such audit above purpose tobira affiliate sublicensee shall keep such account book their relating record document after each calendar quarter concerned table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign adjustment royalty payment should nbsp simple miscalculation royalty amount found nbsp some temporary figure used tobira quarterly calculation sale later actual amount turn different appropriate adjustment needed reflect actual amount sale then necessary adjustment royalty amount shall made within thirty nbsp after receipt either party from other party notification nbsp nbsp mentioned hereinabove except otherwise provided previous sentence this article payment made under article this agreement shall refundable creditable under circumstance reason table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign wire transfer payment made hereunder shall made wire transfer following takeda bank account such other bank account designated takeda written notice received tobira least nbsp before payment table style margin margin bottom margin left font size font family time roman name bank style margin margin bottom margin left font size font family time roman branch style margin margin bottom margin left font size font family time roman account style margin margin bottom margin left font size font family time roman account holder style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign interest late payment late payment shall bear interest thereon rate above prime rate quoted city bank then prevailing from date payment until remittance actually made table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small isclosure small small small small nformation small small small small echnology small small ransfer small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size initial disclosure takeda within thirty nbsp after receipt upfront milestone payment pursuant article takeda shall cost expense nbsp transfer tobira right title interest principal compound principal product filed takeda effective date with regulatory authority territory preparing providing with regulatory authority territory necessary appropriate notification other documentation required complete such transfer tobira nbsp disclose provide tobira information including without limitation substantive correspondence with regulatory authority territory regarding transferred pursuant above subsection with regard principal compound principal product listed initial schedule attached hereto thereafter table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign tobira raise question takeda with regard such information disclosed takeda shall extent reasonable available takeda diligently answer such question takeda shall obligated translate information into english otherwise compile same unless otherwise agreed upon party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign completion disclosure within ninety nbsp after effective date subject after takeda receipt upfront milestone payment pursuant article takeda shall cost expense nbsp transfer tobira right title interest reserve product reserve compound filed takeda effective date with regulatory authority territory preparing providing with regulatory authority territory necessary appropriate notification other documentation required complete such transfer tobira nbsp disclose provide tobira information including without limitation substantive correspondence with regulatory authority territory regarding transferred pursuant above subsection with regard reserve compound reserve product listed initial schedule attached hereto thereafter tobira raise question takeda with regard such information disclosed takeda shall extent reasonable available takeda diligently answer such question takeda answer such question made pursuant this article shall also treated information takeda confidential information table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size continuing obligation takeda event that time during term this agreement takeda should come into possession patent right other than those listed current schedule claim example patent application which specific reference either table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign both compound made then takeda shall promptly disclose same tobira permit tobira such patent right under term condition this agreement such patent right shall added included ancillary patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small evelopment small small small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign development principal compound tobira affiliate sublicensee shall their commercially reasonable effort with respect principal compound conduct development work from effective date primary indication development principal compound secondary indication shall sole discretion tobira event that tobira decides proceed such development secondary indication shall inform takeda thereof writing prior commencement such development thereafter tobira affiliate sublicensee shall also their commercially reasonable effort conduct development work such secondary indication tobira shall report takeda affiliate sublicensee development progress updated development plan from time time frequently than semi annually order enable takeda know status development principal compound table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size development reserve compound tobira shall entitled decide sole discretion whether commence development reserve compound event that tobira decides proceed with such development shall notify takeda thereof writing prior commencement such development thereafter tobira affiliate sublicensee shall also their commercially reasonable effort conduct development work reserve compound table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign shall report takeda their development progress updated development plan from time time frequently than semi annually order enable takeda know status development reserve compound with regard milestone payment forth article already made tobira principal compound that time tobira shall required make same milestone payment even same milestone event occur reserve compound example tobira decides develop commercialize reserve compound after payment pursuant article with regard principal compound then tobira shall obligated make milestone payment pursuant article nbsp with regard reserve compound they have already been paid with respect principal compound however milestone payment that have been triggered will triggered first principal compound reserve compound reach said milestone table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign responsibility from execution this agreement development work shall conducted tobira affiliate sublicensee their sole cost risk responsibility table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size ongoing trial once tobira commences clinical clinical trial compound product hereunder then tobira shall conduct such trial completion unless tobira decision cease such trial prior completion following cause nbsp tobira reasonable judgment there scientific other technical problem including problem which relate safety efficacy toxicology compound product nbsp there significant unexpected change regulatory requirement country concerning development compound product which come into existence after effective date example requirement study table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign specific patient group nbsp tobira reasonable judgment there significant unexpected change market that provide business justification such cessation which come into existence after effective date example competitive product enter market provided however that case subsection nbsp tobira shall complete study patient already commenced tobira decide conduct newly required additional study tobira shall conduct portion trial originally planned before such change regulatory requirement market change case such cessation reason tobira shall responsible winding including without limitation answering request question from patient including continuing provide patient with product appropriate required table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small egulatory small small atters small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign registration tobira affiliate sublicensee shall commercially reasonable effort obtain soon possible approval other country that tobira deems appropriate tobira affiliate sublicensee shall owner such approval table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign maintenance tobira shall obtain secure maintain approval sole cost responsibility table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign cost expense necessary filing application obtaining securing maintaining approval territory shall borne tobira table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign reporting obligation tobira shall keep takeda informed progress application approval each country territory from time time frequently than semi annually order enable takeda know status approval table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small anufacturing small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign manufacturing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign event tobira request takeda agrees solely within nbsp year after receipt upfront milestone payment pursuant article takeda will dispatch takeda researcher employee support tobira manufacturing compound using information tobira shall reimburse expense including reasonable actual travel lodging expense labor cost based upon actual time spent agreed full time equivalent rate such person table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign tobira shall responsible procuring requirement compound product from third party manufacturer manufacturing itself compound product information table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign upon request tobira takeda shall assist tobira introducing tobira third party manufacturer takeda used manufacture compound provided however that takeda shall obligated cause such used third party manufacture enter into agreement with tobira table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign tobira affiliate sublicensees information material provided made available tobira takeda course manufacturing pursuant this article part information purpose developing commercializing product table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign manufacturing responsibility tobira shall manufacture itself through third party manufacturer compound product responsibility expense provided however takeda shall transfer tobira tobira shall accept certain amount principal compound nbsp intermediate material under term condition defined schedule nbsp attached hereto avoidance doubt unless otherwise agreed upon party takeda shall obligated manufacture supply compound product intermediate material beyond quantity forth schedule nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small small small small small small small roduct small small small small eport small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign commercialization tobira shall ensure cause affiliate sublicensee ensure that first commercial sale product each territory made within achieving approval each such country event that tobira fails achieve first commercial sale product country territory within such period tobira shall notify takeda writing reason such failure tobira affiliate sublicensee launch product territory within such period despite applying commercially reasonable effort then tobira shall breach obligation under this article long such situation continues provided that tobira shall have continuing obligation apply commercially reasonable effort launch product soon possible provide reasonable satisfaction takeda from time time status report outlining reason failure launch together with plan later launch appropriate table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign pricing marketing strategy tobira shall solely responsible deciding marketing strategy selling price product each country territory accordance with applicable regulation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign product promotion introduction advertisement sale promotion product well post marketing surveillance other commercialization related action shall made tobira affiliate sublicensee expense responsibility tobira shall cause affiliate sublicensee commercially reasonable effort market promote sell product country territory where product been launched part promotional sale activity required tobira shall carry clinical study such phase territory expense responsibility accordance with protocol prepared tobira tobira shall responsible receiving investigating documenting serious adverse drug reaction relating product which require reporting appropriate regulatory authority territory tobira shall solely responsible filing post marketing report such serious adverse drug reaction required regulatory authority territory required applicable regulation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size compete obligation tobira tobira shall shall cause affiliate sublicensee directly indirectly develop commercialise product containing small molecule compound whose most principal mechanism action chemokine motif receptor antagonist other than product primary indication secondary indication those which product being developed commercialized country territory such product competing product notwithstanding foregoing event that nbsp tobira acquired third party nbsp acquires third party which developing table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign commercializing such competing product either case surviving entity shall have reasonable period time divest competing product which shall case exceed from closing such acquisition event that surviving entity discontinue development commercialization divest itself right obligation develop commercialize such competing product within such time period takeda sole discretion terminate this agreement solely with respect affected product forth article tobira shall construed breaching this compete obligation surviving entity such acquisition just hold competing compound proceed further development commercialization such competing product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign compete obligation takeda takeda shall directly indirectly develop commercialise product containing active ingredient compound specific compound avoidance doubt notwithstanding previous sentence takeda conduct research using compound specific compound research tool such standard compound control compound lead compound research develop commercialize product other than those restricted above table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small epresentation small small small small arranties small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign mutual representation warranty each party hereby represents warrant other party effective date follows table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign such party corporation duly organised validly existing good standing under state nation organization full corporate power authority enter into this agreement carry provision this agreement table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign such party duly authorised execute deliver this agreement perform obligation hereunder person executing this agreement such party behalf been duly authorized requisite corporate action table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign execution delivery performance this agreement conflict with agreement contract instrument understanding oral written which such party party which bound will violate regulation legislature court governmental body administrative agency other authority having jurisdiction over party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign representation warranty takeda takeda hereby represents warrant tobira further that neither takeda affiliate have granted third party license other right practice information manner relating importation offering sale sale compound product anywhere territory manner that would conflict with tobira right granted this agreement takeda full legal right authority grant tobira license other right granted this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size implied warranty save expressly stated this agreement representation condition warranty whatsoever including without limitation takeda warranty efficacy safety merchantability fitness particular purpose compound product infringement misappropriation third party patent other right patentability validity assigned patent ancillary patent made given behalf either party condition warranty implied operation otherwise hereby expressly excluded neither party entered into this agreement reliance upon table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign representation warranty undertaking other party which referred this agreement provided however that this article shall exclude liability remedy respect fraudulent misrepresentation either party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small ndemnification small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnification takeda takeda shall indemnify hold harmless defend tobira affiliate sublicensee distributor their director officer employee agent from against claim including product liability claim loss expense cost defence including attorney witness damage judgment fine amount paid settlement collectively loss resulting from claim claim third party extent that such claim claim arising table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign breach takeda warranty under article article through wilful misconduct negligence table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign clinical clinical testing other development compound product conducted behalf takeda prior effective date table style margin margin bottom margin left font size font family time roman each case except extent such loss arise event described article style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnification tobira tobira shall solely responsible indemnify hold harmless defend takeda affiliate their director officer employee agent from against loss resulting from claim claim third party extent that such claim claim arise table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign breach tobira warranty under article through tobira affiliate sublicensee wilful misconduct negligence table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign clinical clinical testing other development work with respect compound product extent conducted behalf tobira affiliate sublicensee after effective date table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign manufacturing marketing promotion distribution sale other action omission relating compound product territory behalf tobira affiliate sublicensee table style margin margin bottom margin left font size font family time roman each case except extent such loss arise event described article nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign procedure event claim third party against party entitled indemnification under this agreement indemnified party indemnified party shall promptly notify other party indemnifying party within thirty nbsp writing claim indemnifying party shall undertake solely manage control sole expense defence claim settlement permitted under applicable legal ethical requirement indemnifying party defence counsel represent both party separate independent counsel shall retained each party indemnified party shall cooperate with indemnifying party option expense represented such action proceeding counsel choice indemnifying party shall liable litigation cost expense incurred indemnified party without indemnifying party written consent indemnifying party shall settle such claim unless such settlement fully unconditionally release indemnified party from liability relating thereto unless indemnified party otherwise agrees writing table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insurance tobira shall maintain insurance cover consistent with normal business practice adequate cover risk specified under aforementioned provision this article however understood agreed that maintenance such insurance coverage will relieve tobira obligation under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small ecrecy small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidentiality subject other provision this agreement each party agrees that shall during term this agreement period year thereafter hold confidence confidential information other party term condition this agreement shall disclose such confidential information third party such confidential information purpose other than purpose this agreement without first obtaining prior written consent other party notwithstanding foregoing disclosure each party affiliate sublicensee third party whom public health access license granted expressly permitted subject term condition this agreement foregoing obligation shall however apply confidential information which receiving party prove sufficient written evidence that table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign public knowledge prior disclosure providing party receiving party hereunder table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign enters into public domain after disclosure providing party receiving party without breach receiving party this agreement table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign been independently developed receiving party without access confidential information supplied table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign disclosed receiving party third party right make such disclosure table style margin margin bottom margin left font size font family time roman avoidance doubt data information know shall deemed within foregoing exception merely because nbsp such data information know embraced more general information which provably known receiving party nbsp portion thereof provably known receiving party combination thereof well combined entire data information know provably known receiving party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size authorised disclosure further article tobira shall time further entitled disclose confidential information takeda officer employee sublicensees advisor consultant potential business partner investor distributor each country territory regulatory authority territory extent same have need know purpose fulfilling this agreement provided however that tobira shall extent permitted impose upon such disclosees obligation confidentiality least equivalent those imposed tobira hereunder moreover tobira shall further entitled disclose confidential information takeda required disclosed including filing with security exchange commission other stock exchange purpose complying with governmental regulation including without limitation regulation pertaining approval compound product provided however that tobira shall inform takeda such requirement prior disclosure shall cooperate with takeda seek appropriate table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign protective order other protection extent reasonably possible addition takeda tobira shall entitled disclose confidential information other party such confidential information other party required disclosed court order other legal requirement prosecuting defending litigation provided however that such party going disclose other party confidential information shall inform other party such requirement prior disclosure shall cooperate with other party seek appropriate protective order other protection extent reasonably possible table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign publication subject article article tobira shall time entitled publish result development work regarding compound product takeda shall during term this agreement period thereafter entitled publish confidential information related compound product without prior written permission tobira table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign press release other party name party agree that each party issue agreed press release form attached schedule nbsp after effective date except provided above party desire issue press release other public statement concerning execution this agreement must first obtain other party written approval content such proposed release tobira thereafter issue press release with regard product development thereof subject following limitation except required under applicable neither party company name housemarks trademark logo symbol associated with other party without prior written permission such other party table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign injunctive relief each party acknowledges that breach this confidentiality limited obligation relating other party confidential information contained hereunder cause other party continuing irreparable harm which adequately compensated monetary damage each party therefore agrees that event actual threatened breach such obligation notwithstanding provision article hereof disclosing party shall entitled seek addition other remedy available temporary restraining order preliminary final injunctive relief prevent breach this agreement time disclosing party sole discretion without necessity posting bond other security table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small atents small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign obligation maintain tobira shall commercially reasonable effort maintain assigned patent tobira shall responsible maintenance defence prosecution assigned patent name tobira tobira expense takeda shall under obligation except those specifically forth article provided however with regard defence assigned patent tobira receives office action opposition action declaratory judgement nullity action interference declaration infringement reexamination other attack upon validity title enforceability assigned patent tobira shall notify takeda shall conduct defence therefor upon consultation with takeda table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size patent term extension tobira shall commercially reasonable effort apply obtain patent term extension assigned patent tobira shall responsible patent term extension assigned patent tobira shall responsible listing assigned table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign patent list entitled approved drug product with therapeutic equivalence evaluation known orange book case united state equivalence other country expense such patent term extension patent listing shall borne tobira table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign infringement assigned patent tobira shall commercially reasonable effort take appropriate action elimination infringement assigned patent tobira shall responsible such legal proceeding elimination infringement assigned patent expense such legal proceeding shall borne tobira addition event that tobira earns revenue damage cost recovered from legal proceeding pursuant this article with regard assigned patent remaining revenue received after deducting pocket expense incurred such legal proceeding from such revenue shall treated included sale table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign special provision public health access license event that governmental authority other third party proposes threatens grant public health access license under assigned patent information extent allowed applicable tobira shall responsible taking action provided however that tobira shall notify takeda writing thereof tobira shall take such action cost risk responsibility event that tobira shall allowed take such action event that governmental authority other third party proposes threatens grant public health access license under ancillary patent then takeda shall take such action extent allowed applicable applying commercially reasonable effort tobira shall give reasonable assistance connection therewith each party shall bear cost table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign third party suit against takeda tobira event claim threat suit third party against tobira sublicensee takeda alleging that manufacture import formulation sale offer sale compound product territory made hereunder infringes patent other industrial property right such third party each party hereto shall inform other party such claim threat suit tobira shall upon consultation with takeda defend such claim threat suit settlement thereof cost responsibility damage awarded third party result suit infringement such third party patent other industrial property right settlement thereof shall borne solely tobira sublicensee table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small nventions small small small small mprovements small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign invention improvement takeda event that technical information invention discovery whether patentable obtained concerning compound product from activity solely undertaken takeda after effective date such patentable patentable invention shall owned takeda patent application takeda discretion filed under name takeda takeda expense however such patent which specific reference either both compound made claim example patent specification shall included ancillary patent pursuant article table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign invention improvement tobira event that technical information invention discovery whether patentable obtained from activity undertaken tobira affiliate sublicensee pursuant this agreement such patentable patentable invention shall owned tobira affiliate sublicensee patent application tobira discretion filed under name tobira affiliate sublicensee their expense takeda informs tobira that want have license under such patent application patent develop commercialize compound product originated licensed takeda other than compound product tobira shall enter into good faith discussion with takeda such license under term condition meeting then prevailing industrial standard avoidance doubt foregoing provision this article shall interpreted impose upon tobira obligation grant such license takeda unless otherwise separately expressly agreed upon party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small orce small small ajeure small table style margin margin bottom margin left font size font family time roman either party rendered unable fulfil wholly part part obligation under this agreement reason force majeure such party shall forthwith give other party written notice briefly describing circumstance causing such inability thereupon extent that party giving such notice unable fulfil such obligation reason such circumstance such obligation shall suspended during longer than continuance such circumstance force majeure mean requisition interference government state local authority strike lockout riot epidemic disease other circumstance whatsoever whether ejusdem generis above cause over which party shall have control these case other party right demand indemnity damage event force style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman majeure preventing performance shall continue more than nbsp month both party shall good faith negotiate decide cope with situation style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small small small small small greement small small small small ermination small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign term agreement this agreement shall effective from date first above written unless sooner terminated mutual agreement accordance with other provision herein shall remain effect country country product product basis until expiry royalty period table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign termination cause either party terminate this agreement entirety written notice other party with immediate effect following case table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign case either party fails fulfil material obligation under this agreement correct such default material obligation within sixty nbsp counting from date which written notice requiring defaulting party correct such default material obligation posted other party provided however such material breach which cured within such sixty nbsp period such termination right limited following case nbsp defaulting party commence diligently continue action cure such breach default during such sixty nbsp nbsp defaulting party reasonably belief that such material breach cured within hundred twenty nbsp counting from above written notice provided further event such material breach cured within hundred twenty nbsp counting from above written notice then either party terminate this agreement entirety written notice other party with immediate effect table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign case filing other party petition bankruptcy insolvency case filing other party petition answer seeking reorganization readjustment rearrangement business other party under government regulation relating bankruptcy insolvency case appointment receiver substantially property other party case making other party assignment attempted assignment benefit creditor case institution other party proceeding liquidation winding business termination corporate charter table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign termination breach article notwithstanding provision article case breach article where competing product developed commercialized indication which either principal product reserve product being developed commercialized then takeda terminate this agreement only with respect affected product which tobira developing commercializing competing product eliminate such affected product from scope this agreement this agreement will continue with respect affected product effective upon written notice such termination tobira table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size termination tobira tobira terminate this agreement tobira determines that feasible pursue development launch sale product following cause nbsp reasonable judgment there scientific other technical problem including problem which relate safety efficacy toxicology compound product nbsp there significant unexpected change regulatory requirement country concerning table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign development compound product which come into existence after effective date example requirement study specific patient group nbsp there significant unexpected change commercial opportunity compound product which come into existence after effective date such situation continues reasonably expected continue such long time period that longer financially feasible continue develop commercialize product tobira provide written notice takeda such determination together with competent information thereof have serious discussion with takeda regarding what step take regard problem tobira then terminate this agreement effective upon ninety nbsp written notice understood that tobira shall have right demand from takeda compensation termination this agreement pursuant this article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small ffects small small small small reach small small small small ermination small table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign accrued obligation termination this agreement reason shall release party from liability that time such termination already accrued other party preclude either party from pursuing right remedy have table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign consequence expiration termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size upon expiration this agreement with respect product country territory pursuant article tobira shall continue have nbsp perpetual exclusive fully paid licensable right continue make have made further develop have developed sell offer sell import export such compound such product such country under information nbsp blocking covenant granted tobira article table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign with regard ancillary patent blocked such expiration date such compound such product such country shall become perpetual irrevocable same extent that tobira such right immediately prior expiration term table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size event termination this agreement either entirety only with respect product reason then licence granted hereunder either their entirety with respect such terminated product case shall cease with immediate effect tobira shall promptly send back takeda data information furnished takeda with respect product product being terminated case time such termination including without limitation information pertaining thereto tobira shall thereafter them purpose whatsoever provided however nbsp that there going clinical trial clinical study with regard compound product thus terminated once started hereunder tobira affiliate sublicensee tobira shall obligated complete expense responsibility such trial even after termination this agreement provided further case termination tobira pursuant article term condition forth article shall apply case termination pursuant subsection nbsp nbsp article tobira decide conduct newly required additional study shall complete study patient already commenced nbsp tobira shall continue responsible winding including without limitation answering request question from patient including continuing provide patient with product table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign appropriate required coordination with governing regulatory agency other relevant organization relating thereto event that termination tobira takeda breach insolvency pursuant article then takeda shall reimburse tobira reasonable cost actually incurred after effective date such termination connection with continuation such trial table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign event that takeda terminates this agreement under article event that tobira terminates this agreement under article addition other consequence termination forth herein requested takeda nbsp tobira shall immediately transfer assign back takeda designee assigned patent abandon assigned patent tobira cost nbsp tobira shall transfer takeda designee approval application therefor data information obtained tobira affiliate sublicensee including without limitation result development work conducted them inds development work result going development work otherwise assist takeda designee that takeda designee smoothly take over development commercialization product transfer assistance tobira accordance with previous sentence this article shall made free takeda designee charge table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size with respect sublicensee tobira that breach their sublicense agreement under which tobira imposed such sublicensee applicable obligation which tobira table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign undertakes hereunder such sublicensee desire continue development commercialization product takeda shall enter into good faith negotiation assuming such sublicense agreement otherwise direct license from takeda such sublicensee provided however that takeda shall obligated assume obligation under such agreement that excess obligation takeda under this agreement unless takeda agrees otherwise sole discretion table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign disposal product event termination this agreement either entirety with respect product country territory reason disposal compound good process product tobira stock effective date termination shall made following manner table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign tobira manufacture product using such compound such good process sell product territory regular commercial condition only term nbsp year after such termination subject tobira agreement strictly observe term condition contained this agreement including obligation royalty accordance with article provided that event termination takeda pursuant article article foregoing shall apply only takeda consent which consent shall unreasonably withheld table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size event termination takeda pursuant article article tobira pursuant article requested takeda tobira shall promptly after such takeda request subject tobira right table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign complete manufacture good process sell product provided above subsection sell takeda remaining portion stock compound product only that portion stock that sufficient shelf life remaining meet specification agreed upon party well then current regulatory specification approved relevant regulatory authority price negotiated decided party which price shall higher than fully burdened cost good table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign case tobira shall destroy stock which meet specification otherwise used sold pursuant above subsection nbsp nbsp tobira expense responsibility without requiring takeda compensation therefor table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign survival clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign upon expiry termination this agreement provision shall survive other article schedule this agreement which expressed which meaning implied survive termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign expiry termination this agreement reason shall without prejudice right that shall have accrued benefit either party prior such termination expiration table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small imitation small small small small iability small table style margin margin bottom margin left font size font family time roman neither party shall liable other special consequential incidental indirect damage arising from relating breach this agreement regardless notice style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman possibility such damage notwithstanding foregoing nothing this article nbsp intended limit restrict indemnification right obligation party under article nbsp damage available breach confidentiality obligation under article nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small ssignment small table style margin margin bottom margin left font size font family time roman this agreement right obligation created under this agreement shall assignable either party hereto without prior written consent other party which shall unreasonably withheld delayed except that each party assign this agreement successor interest pursuant merger acquisition reorganization consolidation sale substantially asset business which this agreement relates attempted assignment that comply with requirement this article shall null void this agreement shall binding upon each party their successor permitted assigns style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small everability small table style margin margin bottom margin left font size font family time roman provision provision this agreement shall extent invalid unenforceable remainder this agreement shall affected thereby shall valid enforceable fullest extent permitted however case such invalidation unenforceability injures right interest either party party hereto shall renegotiate this agreement good faith style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small ntire small small greement small small odification small table style margin margin bottom margin left font size font family time roman this agreement constitutes entire final complete agreement understanding between party replaces supersedes prior discussion agreement between them with respect subject matter hereof modification amendment this agreement shall valid binding upon party hereto unless made writing duly executed behalf each party hereto style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small fficial small small small small small small overning small small small table style margin margin bottom margin left font size font family time roman english version this agreement subscribed executed party hereto shall official text this agreement shall governed interpreted accordance with state york without reference conflict provision style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small otice small table style margin margin bottom margin left font size font family time roman notice required given either party connection with this agreement shall given english language prepaid airmail cable telex facsimile addressed other party principal office first above written following attention style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign tobira address number table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign takeda general manager global licensing nbsp business development table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small rbitration small table style margin margin bottom margin left font size font family time roman dispute arising connection with this agreement which settled amicable between party hereto shall finally settled under rule conciliation arbitration international chamber commerce more arbitrator appointed accordance with rule award rendered shall final binding upon both party such arbitration shall held osaka japan initiated tobira diego initiated takeda style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman language arbitration shall english total expense such arbitration including reasonable attorney shall borne unsuccessful party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small onstruction small table style margin margin bottom margin left font size font family time roman this agreement been prepared jointly shall strictly construed against either party ambiguity this agreement shall construed against party without regard which party deemed have authored ambiguous provision heading each section this agreement have been inserted convenience reference only intended limit expand meaning language contained particular section style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small ounterparts small table style margin margin bottom margin left font size font family time roman this agreement executed more counterpart each which shall original which shall constitute together same document style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left article nbsp align left valign small aiver small table style margin margin bottom margin left font size font family time roman delay enforcing party right under this agreement waiver particular default other matter shall constitute waiver such party right future enforcement right under this agreement unless such party provides express written signed waiver particular matter particular period time style margin margin bottom font size font family time roman align center remainder intentionally left blank style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman witness whereof party have caused this agreement executed their duly authorized officer duplicate year first above written each text this agreement shall held either party hereto style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign colspan takeda pharmaceutical company limited style font size height colspan style font family time roman font size valign colspan style margin margin bottom border bottom solid text indent font size font family time roman style font family time roman font size valign name valign bottom valign style font family time roman font size valign title valign bottom valign style font size height colspan style font family time roman font size valign colspan tobira therapeutic style font size height colspan style font family time roman font size valign colspan style margin margin bottom border bottom solid text indent font size font family time roman style font family time roman font size valign name valign bottom valign style font family time roman font size valign title valign bottom valign table style margin margin bottom font size font family time roman schedule style margin margin bottom font size font family time roman schedule list current income country style margin margin bottom font size font family time roman schedule assigned patent style margin margin bottom font size font family time roman schedule information list style margin margin bottom font size font family time roman schedule specific compound style margin margin bottom font size font family time roman schedule ancillary patent style margin margin bottom font size font family time roman schedule sample supply style margin margin bottom font size font family time roman schedule press release style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center list current income country style margin margin bottom font size font family time roman income economy nbsp style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign align center valign bottom valign align center valign bottom valign align center table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center assigned patent style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign principal compound table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom font size font family time roman takeda style margin margin bottom border bottom solid width font size font family time roman case valign bottom nbsp valign bottom nowrap style border bottom solid width font size font family time roman country valign bottom nbsp valign bottom nowrap style margin margin bottom font size font family time roman application style margin margin bottom border bottom solid width font size font family time roman filing date valign bottom nbsp valign bottom nowrap style margin margin bottom font size font family time roman patent style margin margin bottom border bottom solid width font size font family time roman issue date style font family time roman font size valign valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign reserve compound table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style margin margin bottom font size font family time roman takeda style margin margin bottom border bottom solid width font size font family time roman case valign bottom nbsp valign bottom nowrap style border bottom solid width font size font family time roman country valign bottom nbsp valign bottom nowrap style margin margin bottom font size font family time roman application style margin margin bottom border bottom solid width font size font family time roman filing date valign bottom nbsp valign bottom nowrap style margin margin bottom font size font family time roman patent style margin margin bottom border bottom solid width font size font family time roman issue date style font family time roman font size valign valign bottom nbsp valign bottom valign bottom nbsp valign bottom valign bottom nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center information list style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign clinical part table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign principal compound table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman document nbsp number valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman title style font family time roman font size valign valign bottom nbsp nbsp valign bottom table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign reserve compound table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman document nbsp number valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman title style font family time roman font size valign valign bottom nbsp nbsp valign bottom table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign clinical part table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign principal compound table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman document nbsp number valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman title style font family time roman font size valign valign bottom nbsp nbsp valign bottom table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign reserve compound table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman document nbsp number valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman title style font family time roman font size valign valign bottom nbsp nbsp valign bottom table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign part table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign principal compound table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman document nbsp valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman title valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman comment style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman document nbsp valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman title style font family time roman font size valign valign bottom nbsp nbsp valign bottom table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign reserve compound table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman drug substance document title valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman comment style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font size height height colspan style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman intermediate document title valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman comment style font family time roman font size valign valign bottom nbsp nbsp valign bottom table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman document nbsp valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman title style font family time roman font size valign valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center specific compound style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center ancillary patent style margin margin bottom font size font family time roman principal compound style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap align center style border bottom solid width font size font family time roman align center takeda case valign bottom nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center country valign bottom nbsp valign bottom nowrap align center style margin margin bottom font size font family time roman align center application filing style margin margin bottom border bottom solid width font size font family time roman align center date valign bottom nbsp valign bottom nowrap align center style margin margin bottom font size font family time roman align center patent style margin margin bottom border bottom solid width font size font family time roman align center issue date style font family time roman font size valign align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style margin margin bottom font size font family time roman reserve compound style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap align center style border bottom solid width font size font family time roman align center takeda case valign bottom nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center country valign bottom nbsp valign bottom nowrap align center style margin margin bottom font size font family time roman align center application filing style margin margin bottom border bottom solid width font size font family time roman align center date valign bottom nbsp valign bottom nowrap align center style margin margin bottom font size font family time roman align center patent style margin margin bottom border bottom solid width font size font family time roman align center issue date style font family time roman font size valign align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center sample supply style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign quantity supplied table style margin margin bottom margin left font size font family time roman principal compound bulk compound style margin margin bottom margin left font size font family time roman style margin margin bottom margin left font size font family time roman style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign delivery timing table style margin margin bottom margin left font size font family time roman within nbsp month after takeda receipt upfront milestone pursuant article style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign purpose table style margin margin bottom margin left font size font family time roman tobira shall principal compound thus supplied solely preliminary study shall unless otherwise approved takeda pursuant hereto them human style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign plan work table style margin margin bottom margin left font size font family time roman within twenty nbsp after receipt principal compound hereunder tobira shall provide plan takeda which shall include whole part plan proposal that tobira will either itself through third party manufacturer crystallize purify part principal compound among from under cgmp condition conform regulation human hereinafter called work takeda shall have forty nbsp after receipt such plan review thereof takeda find sole discretion such proposal work acceptable then takeda shall inform tobira same writing subject such acceptance takeda tobira plan thereafter tobira subject making second payment tobira takeda supply price pursuant following item nbsp hereof which shall upon such takeda acceptance work principal compound thus approved principal compound thus worked from principal compound supplied human provided however tobira shall fully responsible such working principal compound further such worked principal compound takeda shall have responsibility therefor style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom margin left font size font family time roman avoidance doubt takeda approve plan takeda shall obligated return first payment received pursuant item nbsp nbsp hereof tobira shall obligated make second payment payable pursuant item nbsp nbsp hereof principal compound further shall dispose remaining principal compound tobira cost responsibility without delay send takeda written certificate such disposal style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign supply price table style margin margin bottom margin left font size font family time roman style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign shipping trade term incoterms table style margin margin bottom margin left font size font family time roman style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign quality table style margin margin bottom margin left font size font family time roman tobira acknowledges that principal compound supplied hereunder supplied basis from current takeda inventory without conducting quality check style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign warranty table style margin margin bottom margin left font size font family time roman takeda will make representation warranty whatsoever with regard supplied principal compound including without limitation their quality such conforming certain specification manufactured accordance with style margin margin bottom margin left font size font family time roman addition takeda shall make representation warranty whether such approval otherwise with regard such working principal compound further such worked principal compound including without limitation fitness principal compound supplied such work reasonableness successfulness such work efficacy safety usability human conforming certain specification other quality worked principal compound style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign additional supply intermediate material table style margin margin bottom margin left font size font family time roman effective date takeda posse following intermediate material inventory style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman category valign bottom nbsp nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center sample nbsp name valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid quantity nbsp valign bottom nbsp valign bottom nbsp nbsp valign bottom colspan align center style border bottom solid unit nbsp price nbsp valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp valign bottom nbsp nbsp valign bottom nbsp valign bottom align right nowrap valign bottom nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman within eighty nbsp after effective date tobira provide additional plan takeda which shall include whole part plan proposal that tobira will purchase certain amount such intermediate material among from such takeda inventory will either itself through third party manufacturer manufacture principal compound under cgmp condition conform regulation human hereinafter called completion style margin margin bottom font size font family time roman takeda will have forty nbsp after receipt such plan review thereof takeda find sole discretion such proposal completion acceptable then takeda shall inform tobira such decision writing such case style margin margin bottom font size font family time roman takeda shall transfer tobira tobira shall accept intermediate material identified approved plan style margin margin bottom font size font family time roman delivery timing such intermediate material shall within nbsp month after takeda notice acceptance style margin margin bottom font size font family time roman supply price such intermediate material shall calculated based unit price forth above intermediate material schedule shall upon delivery thereof shall paid tobira takeda within fifteen nbsp after delivery concerned intermediate material style margin margin bottom font size font family time roman shipping trade term shall osaka incoterms basis style margin margin bottom font size font family time roman tobira acknowledges that intermediate material supplied hereunder supplied basis from current takeda inventory without conducting quality check takeda will make representation warranty whatsoever with regard supplied intermediate material including without limitation their quality such conforming certain specification manufactured accordance with style margin margin bottom font size font family time roman tobira shall fully responsible completion intermediate material into principal compound further such completed principal compound takeda shall have responsibility therefor style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman takeda shall make representation warranty whether such approval otherwise with regard such completion intermediate material into principal compound further such completed principal compound including without limitation fitness intermediate material supplied such completion reasonableness successfulness such completion efficacy safety usability human conforming certain specification other quality completed principal compound style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center press release style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign style margin margin bottom logo style font size margin margin bottom nbsp style margin margin bottom font size font family time roman immediate release valign bottom valign style margin margin bottom logo style font size margin margin bottom nbsp style margin margin bottom font size font family time roman contact style font size margin margin bottom nbsp style margin margin bottom font size font family time roman james sapirstein style margin margin bottom font size font family time roman tobira therapeutic style margin margin bottom font size font family time roman style font size margin margin bottom nbsp style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman takeda pharmaceutical company limited style margin margin bottom font size font family time roman table style margin margin bottom font size font family time roman align center takeda license antagonist treatment infection tobira therapeutic style margin margin bottom text indent font size font family time roman osaka japan diego august nbsp takeda pharmaceutical company limited takeda tobira therapeutic tobira today announced that they have entered into agreement pursuant which exclusive worldwide right develop manufacture commercialize takeda anti investigational compound granted tobira style margin margin bottom text indent font size font family time roman upon conclusion agreement takeda will receive from tobira upfront payment well development commercialization milestone payment royalty sale product further detail economic condition disclosed style margin margin bottom text indent font size font family time roman antagonist that administered orally bind receptor interfere with entry virus into macrophage activated cell inhibiting fusion between viral cellular membrane style margin margin bottom text indent font size font family time roman this mechanism action different from those currently used treatment infection such nucleoside reverse transcriptase inhibitor protease inhibitor currently phase clinical development europe future development activity these territory will conducted tobira style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom text indent font size font family time roman delighted have opportunity further develop potentially best class tobira focus treatment infection look forward working with researcher community other important partner bring these compound market expeditiously possible benefit patient their loved said james sapirstein tobira style margin margin bottom text indent font size font family time roman expect that development activity will successfully conducted tobira whose management team excellent expertise field research development anti investigational compound that these compound will offer treatment option this disease said nbsp kiyoshi kitazawa managing director general manager strategic product planning department takeda style margin margin bottom font size font family time roman about tobira therapeutic style margin margin bottom text indent font size font family time roman tobira therapeutic private biopharmaceutical company which focused developing commercializing innovative antiviral compound treat disease company founded eckard weber partner venture capital firm domain associate develop novel treatment disease tobira assembled highly experienced management team with decade clinical commercial development experience specifically style margin margin bottom font size font family time roman about takeda pharmaceutical company limited style margin margin bottom text indent font size font family time roman located osaka japan takeda research based global company with main focus pharmaceutical largest pharmaceutical company japan global leader industry takeda committed striving toward better health individual progress medicine developing superior pharmaceutical product additional information about takeda available through corporate website takeda style margin margin bottom font size font family time roman align center style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center confidential style margin margin bottom font size font family time roman certain information this document been omitted filed separately with security exchange commission confidential treatment been requested with respect omitted portion style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center body html text document